BioNTech (BNTX) Competitors $110.05 +0.05 (+0.05%) Closing price 04:00 PM EasternExtended Trading$110.07 +0.02 (+0.02%) As of 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNTX vs. GSK, TAK, ARGX, ONC, TEVA, INSM, SMMT, ITCI, GMAB, and RDYShould you be buying BioNTech stock or one of its competitors? The main competitors of BioNTech include GSK (GSK), Takeda Pharmaceutical (TAK), argenex (ARGX), BeOne Medicines (ONC), Teva Pharmaceutical Industries (TEVA), Insmed (INSM), Summit Therapeutics (SMMT), Intra-Cellular Therapies (ITCI), Genmab A/S (GMAB), and Dr. Reddy's Laboratories (RDY). These companies are all part of the "pharmaceutical products" industry. BioNTech vs. Its Competitors GSK Takeda Pharmaceutical argenex BeOne Medicines Teva Pharmaceutical Industries Insmed Summit Therapeutics Intra-Cellular Therapies Genmab A/S Dr. Reddy's Laboratories GSK (NYSE:GSK) and BioNTech (NASDAQ:BNTX) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, media sentiment, valuation and profitability. Do institutionals & insiders believe in GSK or BNTX? 15.7% of GSK shares are held by institutional investors. Comparatively, 15.5% of BioNTech shares are held by institutional investors. 10.0% of GSK shares are held by company insiders. Comparatively, 19.2% of BioNTech shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Do analysts rate GSK or BNTX? GSK presently has a consensus price target of $37.38, indicating a potential downside of 2.19%. BioNTech has a consensus price target of $137.86, indicating a potential upside of 25.27%. Given BioNTech's stronger consensus rating and higher possible upside, analysts clearly believe BioNTech is more favorable than GSK.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score GSK 1 Sell rating(s) 8 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.10BioNTech 0 Sell rating(s) 4 Hold rating(s) 13 Buy rating(s) 1 Strong Buy rating(s) 2.83 Does the media refer more to GSK or BNTX? In the previous week, GSK had 13 more articles in the media than BioNTech. MarketBeat recorded 15 mentions for GSK and 2 mentions for BioNTech. GSK's average media sentiment score of 0.87 beat BioNTech's score of 0.47 indicating that GSK is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment GSK 9 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BioNTech 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, GSK or BNTX? GSK has a beta of 0.5, meaning that its stock price is 50% less volatile than the S&P 500. Comparatively, BioNTech has a beta of 1.29, meaning that its stock price is 29% more volatile than the S&P 500. Which has higher valuation & earnings, GSK or BNTX? GSK has higher revenue and earnings than BioNTech. BioNTech is trading at a lower price-to-earnings ratio than GSK, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGSK$40.10B1.95$3.29B$1.9419.70BioNTech$2.98B8.89-$719.92M-$3.40-32.37 Is GSK or BNTX more profitable? GSK has a net margin of 9.89% compared to BioNTech's net margin of -27.37%. GSK's return on equity of 48.82% beat BioNTech's return on equity.Company Net Margins Return on Equity Return on Assets GSK9.89% 48.82% 11.15% BioNTech -27.37%-3.94%-3.41% SummaryGSK beats BioNTech on 10 of the 16 factors compared between the two stocks. Get BioNTech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BNTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNTX vs. The Competition Export to ExcelMetricBioNTechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$26.45B$2.86B$5.45B$8.93BDividend YieldN/A2.44%5.22%4.01%P/E Ratio-32.3720.4427.2420.06Price / Sales8.89283.79426.37117.54Price / CashN/A41.7026.2128.59Price / Book1.267.397.925.56Net Income-$719.92M-$55.04M$3.17B$248.56M7 Day Performance3.36%3.43%4.40%7.56%1 Month Performance1.44%0.16%2.64%8.54%1 Year Performance37.41%4.49%35.04%21.81% BioNTech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNTXBioNTech2.3746 of 5 stars$110.05+0.0%$137.86+25.3%+36.9%$26.45B$2.98B-32.376,772GSKGSK2.3336 of 5 stars$38.38-0.5%$37.38-2.6%-1.5%$78.58B$31.53B19.7890,100TAKTakeda Pharmaceutical1.2768 of 5 stars$15.46+2.4%N/A+17.7%$49.19B$30.09B70.2847,300ARGXargenex4.3708 of 5 stars$551.22-1.6%$729.93+32.4%+24.7%$33.66B$2.58B34.00650High Trading VolumeONCBeOne Medicines2.988 of 5 stars$242.07+0.4%$320.67+32.5%N/A$26.53B$3.81B-65.079,000TEVATeva Pharmaceutical Industries4.218 of 5 stars$16.76flat$24.13+43.9%+4.0%$19.22B$16.54B-14.5736,800Positive NewsOptions VolumeINSMInsmed4.5598 of 5 stars$100.64+1.2%$106.80+6.1%+40.7%$19.09B$363.71M-16.91740Positive NewsSMMTSummit Therapeutics2.4826 of 5 stars$21.28+3.3%$35.09+64.9%+236.3%$15.80B$700K-62.59110Gap DownITCIIntra-Cellular Therapies0.9401 of 5 stars$131.87flat$109.70-16.8%N/A$14.05B$680.50M-151.57560GMABGenmab A/S3.8546 of 5 stars$20.66+0.8%$37.60+82.0%-20.1%$13.25B$3.12B11.742,682RDYDr. Reddy's Laboratories2.6856 of 5 stars$15.03-0.3%$16.95+12.8%-3.4%$12.55B$3.81B22.7727,811 Related Companies and Tools Related Companies GSK Competitors Takeda Pharmaceutical Competitors argenex Competitors BeOne Medicines Competitors Teva Pharmaceutical Industries Competitors Insmed Competitors Summit Therapeutics Competitors Intra-Cellular Therapies Competitors Genmab A/S Competitors Dr. Reddy's Laboratories Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNTX) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.